Iduren Sr (Indapamide)

Indapamide blocks the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney. By inhibiting reabsorption of these ions, it promotes the excretion of water and salts, which decreases blood volume and peripheral vascular resistance, ultimately lowering arterial pressure.

The exact dose of Iduren Sr is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Typical adult dosing ranges are established in clinical guidelines, but the prescriber will select the appropriate strength and frequency for each patient.

Safety data for indapamide during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their healthcare provider.

To order Iduren Sr, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indapamide offers a longer duration of action and a more favorable metabolic profile compared with many thiazide diuretics, showing less impact on blood glucose and lipid levels. It is often chosen when clinicians need effective blood‑pressure control with a lower risk of metabolic side effects.

Iduren Sr tablets should be stored at room temperature, below 25 °C, in their original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in humid or excessively hot environments.

Iduren Sr is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber. Consistency in timing helps maintain stable blood‑pressure control.

Serious risks include severe dehydration, electrolyte imbalances such as hyponatremia or hypokalemia, marked hypotension, and rare allergic reactions. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, muscle weakness, severe dizziness, or signs of an allergic response.

Iduren Sr is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide‑derived drugs, severe renal impairment, and in those with anuria. Caution is also advised for individuals with uncontrolled electrolyte disturbances or severe liver disease.